Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA - Multiple System Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04287270
What this trial is testing

Respiratoy Muscle Strength in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Marmara University 19
Not applicableStudy completedNCT00743561
What this trial is testing

Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)

Who this might be right for
Sleep Apnea SyndromesMultiple System Atrophy
University Hospital, Bordeaux 30
Not applicableStudy completedNCT05621200
What this trial is testing

Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia

Who this might be right for
AtaxiaSpinocerebellar AtaxiasMultiple System Atrophy+2 more
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 26
Testing effectiveness (Phase 2)Looking for participantsNCT06831500
What this trial is testing

Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.

Who this might be right for
Multi-system Atrophy - Parkinsonian TypeOrthostatic Hypotension, DysautonomicParkinson Disease
Julien Bally 36
Testing effectiveness (Phase 2)Looking for participantsNCT06162013
What this trial is testing

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Who this might be right for
Progressive Supranuclear PalsyMultiple System AtrophyCorticobasal Syndrome
Haukeland University Hospital 330
Not applicableEnded earlyNCT01607268
What this trial is testing

Magnetic Resonance Spectroscopy in Autonomic Failure

Who this might be right for
Pure Autonomic FailureMultiple System Atrophy
Vanderbilt University 6
Not applicableStudy completedNCT03452956
What this trial is testing

Cognitive Impairement In Frontotemporal Dementia

Who this might be right for
Frontotemporal DegenerationProgressive Supranuclear PalsyMultiple System Atrophy
University of Pennsylvania 997
Post-approval studies (Phase 4)Study completedNCT03924414
What this trial is testing

Trial of Parkinson's And Zoledronic Acid

Who this might be right for
Parkinson DiseaseOsteoporosisParkinsonism+6 more
California Pacific Medical Center Research Institute 2,721
Very early researchStudy completedNCT04616456
What this trial is testing

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Who this might be right for
Multiple System AtrophyMultiple System Atrophy, Cerebellar VariantMultiple System Atrophy, Parkinson Variant (Disorder)+1 more
Brigham and Women's Hospital 19
Not applicableLooking for participantsNCT04782284
What this trial is testing

Comprehensive Swallowing Rehabilitation in Patients With MSA

Who this might be right for
Multiple System Atrophy
Seoul National University Hospital 24
Not applicableLooking for participantsNCT07353463
What this trial is testing

Shanghai Clinical Cohort - Parkinson's Disease (Reserve)

Who this might be right for
Parkinson's Disease (PD)Multiple System Atrophy
Ruijin Hospital 700
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729852
What this trial is testing

Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

Who this might be right for
Multiple System Atrophy
Alterity Therapeutics 5
Early research (Phase 1)Not Yet RecruitingNCT06607900
What this trial is testing

HUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+3 more
Xuanwu Hospital, Beijing 120
Early research (Phase 1)Study completedNCT02429557
What this trial is testing

Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

Who this might be right for
Orthostatic HypotensionPure Autonomic FailureMultiple System Atrophy+1 more
Vanderbilt University Medical Center 21
Not applicableEnded earlyNCT04020198
What this trial is testing

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Who this might be right for
Parkinson DiseaseMultiple System AtrophyRapid Eye Movement Sleep Behavior Disorder+1 more
Stony Brook University 8
Not applicableActive Not RecruitingNCT05792332
What this trial is testing

Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

Who this might be right for
Atypical ParkinsonismMSA - Multiple System AtrophyPSP+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 164
Not applicableUnknownNCT04313530
What this trial is testing

TMS Treatment in Multiple System Atrophy With Fatigue

Who this might be right for
Transcranial Magnetic StimulationMultiple System AtrophyFatigue
Xuanwu Hospital, Beijing 22
Not applicableStudy completedNCT01155492
What this trial is testing

Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
Rush University Medical Center 43
Very early researchLooking for participantsNCT07476352
What this trial is testing

Expansion Study of ALT001 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
yilong Wang 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Next Page